DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015

Promoter bought stakeOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹20.20

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+3.0% vs market

Pharmaceuticals peers, median of 157sector-1.3%+3.7% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4-0.6+3.0-1.3+3.7

Next day

-4.7+0.4-5.1-0.7-4.0

-1.0+3.1-4.1+0.3-1.3

+3.9+0.2+3.7-1.3+5.2

+5.9+1.1+4.9-0.4+6.4

+1.5-3.6+5.1-4.2+5.7

+0.5+1.5-1.0-0.5+1.0

15d

+28.7+6.5+22.1+3.8+24.9

+21.4+12.8+8.6+7.9+13.5

-0.5+15.4-15.9+9.7-10.2

+16.3+24.3-8.0+12.8+3.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sudhir Sethi, the main Promoter and Director of Beryl Drugs Ltd (DIN: 00090172), has bought 15,000 equity shares of the company through an on-market purchase on March 13, 2026. This acquisition represents 0.29% of the company's share capital. As a result, his total holding has increased from 4,55,143 shares (18.98%) to 4,70,143 shares (19.27%). The disclosure was filed under SEBI's Insider Trading Regulations, as required for promoter share purchases.

Likely market impact

This is a small insider buy by the promoter, which is generally viewed as a mildly positive signal showing promoter confidence in the company. However, the size of the purchase (just 0.29%) is too small to materially shift shareholder sentiment or drive significant stock price movement.